Vascular Diseases  >>  Tracleer (bosentan)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tracleer (bosentan) / J&J, Roche
NCT00086463: Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)

Completed
2
60
US
Iloprost or placebo
Actelion
Pulmonary Arterial Hypertension, Ayerza Syndrome, Pulmonary Hypertension
01/06
01/06
NCT00377455: Placebo Controlled Trial of Bosentan in Scleroderma Patients

Terminated
2
5
US
Bosentan, Placebo
Georgetown University, Actelion
Systemic Scleroderma, Pulmonary Hypertension
09/09
03/10
NCT00825266: Insulin Resistance in Pulmonary Arterial Hypertension

Terminated
2
2
US
bosentan, Tracleer, Pioglitazone, Actos
Stanford University
Hypertension, Pulmonary
05/10
05/10
BOSAS, NCT00777985 / 2007-005333-11: Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea

Completed
2
19
Europe
bosentan, TRACLEER, nasal continuous positive airway pressure (CPAP)
University Hospital, Grenoble, Institut National de la Santé Et de la Recherche Médicale, France, Actelion
Obstructive Sleep Apnea, Hypertension
01/12
01/12

Download Options